In a nutshell This study investigated the effectiveness and safety of incobotulinumtoxin A (IBTA) for the treatment of excessive salivation (sialorrhea) in patients with Parkinson disease or stroke. Researchers suggested that IBTA might be a well-tolerated option for the treatment of these patients. Some background Sialorrhea (excessive...
Read MoreSide effects or complications-Problems eating or swallowing Posts on Medivizor
